Eugeni Saigí

1.2k total citations
32 papers, 911 citations indexed

About

Eugeni Saigí is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Eugeni Saigí has authored 32 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Eugeni Saigí's work include Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Treatments and Mutations (6 papers). Eugeni Saigí is often cited by papers focused on Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Treatments and Mutations (6 papers). Eugeni Saigí collaborates with scholars based in Spain, United States and France. Eugeni Saigí's co-authors include Carles Pericay, Kazimierz Roszkowski, A P Smith, Ulf Aasebø, Robert Olivares, Maciej Krzakowski, A Płużańska, J. Bérille, Guillermo Marcos and E. Dotor and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

Eugeni Saigí

30 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugeni Saigí Spain 13 477 384 231 208 194 32 911
Junichi Kaganoi Japan 20 215 0.5× 381 1.0× 299 1.3× 380 1.8× 127 0.7× 37 1.0k
Masahito Tanimizu Japan 15 190 0.4× 132 0.3× 201 0.9× 235 1.1× 134 0.7× 49 734
Manabu Yamamura Japan 15 236 0.5× 250 0.7× 288 1.2× 170 0.8× 128 0.7× 43 862
Chew Wun Wu Taiwan 16 380 0.8× 202 0.5× 318 1.4× 321 1.5× 228 1.2× 34 901
Stella A. V. Nieuwenburg Netherlands 12 291 0.6× 549 1.4× 238 1.0× 120 0.6× 80 0.4× 18 854
Roberto Mencarelli Italy 15 484 1.0× 179 0.5× 417 1.8× 77 0.4× 167 0.9× 36 919
Theresa Nguyen Wenker United States 14 459 1.0× 202 0.5× 600 2.6× 167 0.8× 152 0.8× 27 938
Prachi Patil India 17 372 0.8× 687 1.8× 565 2.4× 322 1.5× 157 0.8× 85 1.3k
Reiko Masunaga Japan 14 496 1.0× 259 0.7× 441 1.9× 223 1.1× 130 0.7× 20 1.0k
Balraj Mittal India 20 185 0.4× 306 0.8× 241 1.0× 284 1.4× 132 0.7× 43 837

Countries citing papers authored by Eugeni Saigí

Since Specialization
Citations

This map shows the geographic impact of Eugeni Saigí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugeni Saigí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugeni Saigí more than expected).

Fields of papers citing papers by Eugeni Saigí

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugeni Saigí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugeni Saigí. The network helps show where Eugeni Saigí may publish in the future.

Co-authorship network of co-authors of Eugeni Saigí

This figure shows the co-authorship network connecting the top 25 collaborators of Eugeni Saigí. A scholar is included among the top collaborators of Eugeni Saigí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugeni Saigí. Eugeni Saigí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martínez-Vila, Clara, Carles Pericay, Javier Serra, et al.. (2018). A real world analysis of recurrence risk factors for early colorectal cancer T1 treated with standard endoscopic resection.. Journal of Clinical Oncology. 36(4_suppl). 575–575. 1 indexed citations
2.
Pericay, Carles, Ferrán Losa, Luis Cirera, et al.. (2016). Phase II study with docetaxel (D), cisplatin (C) and continuous capecitabine (X) schedule (DCX) in advanced gastric cancer (AGC): ML21085. Final results.. Journal of Clinical Oncology. 34(15_suppl). e15520–e15520. 1 indexed citations
3.
Ruiz, Anna, Gemma Llort, Neus Baena, et al.. (2014). Genetic Testing in Hereditary Breast and Ovarian Cancer Using Massive Parallel Sequencing. BioMed Research International. 2014. 1–8. 13 indexed citations
4.
Pericay, Carles, Anna Ferrer, E. Dotor, et al.. (2013). microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers. Oncology Reports. 30(1). 320–326. 142 indexed citations
5.
Gallego, Rosa, Marta Martín-Richard, Carles Pericay, et al.. (2012). Phase II study of oxaliplatin and sorafenib in advanced gastric cancer after failure of cisplatin-fluoropyrimidine-based (PF) treatment.. Journal of Clinical Oncology. 30(15_suppl). 4079–4079. 4 indexed citations
6.
Dalmau, E., et al.. (2010). Efficacy and safety of intrapericardial bleomycin for malignant pericardial effusion.. Journal of Clinical Oncology. 28(15_suppl). e19687–e19687. 3 indexed citations
7.
Pericay, Carles, et al.. (2009). Extravasation of oxaliplatin: an infrequent and irritant toxicity. Clinical & Translational Oncology. 11(2). 114–116. 10 indexed citations
8.
Seguí, Miguel Ángel, Xavier Andreu, E. Dalmau, et al.. (2007). Analysis of the Pathologic Response to Primary Chemotherapy in Patients with Locally Advanced Breast Cancer Grouped According to Estrogen Receptor, Progesterone Receptor, and HER2 Status. Clinical Breast Cancer. 7(7). 559–564. 29 indexed citations
9.
Darnell, Anna, E. Dalmau, Carles Pericay, et al.. (2006). Gastrointestinal stromal tumors. Abdominal Imaging. 31(4). 387–399. 34 indexed citations
10.
Salud, Antonieta, E. Batiste-Alentorn, Eugeni Saigí, et al.. (2005). Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer. European Journal of Cancer. 41(15). 2241–2249. 9 indexed citations
11.
Saigí, Eugeni, E. Batiste-Alentorn, António Galán de Mera, et al.. (2005). Phase II study of weekly irinotecan (CPT-11) associated to protracted oral tegafur (TGF) in previously untreated, advanced colorectal cancer (ACRC). Journal of Clinical Oncology. 23(16_suppl). 3725–3725. 1 indexed citations
12.
13.
14.
15.
Cirera, Luis, A. Balil, E. Batiste-Alentorn, et al.. (1999). Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer. Journal of Clinical Oncology. 17(12). 3810–3815. 88 indexed citations
16.
Seguí, Miguel Ángel, et al.. (1998). Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma. Cancer. 83(2). 254–258. 2 indexed citations
17.
Saigí, Eugeni, et al.. (1995). Clinical Experience with Tegafur and Low Dose Oral Leucovorin: A Dose-Finding Study. Oncology. 52(2). 167–169. 5 indexed citations
18.
González, Carlos A., Jesús M. Sanz, Gerardo Rojo-Marcos, et al.. (1993). Borage consumption as a possible gastric cancer protective factor.. PubMed. 2(2). 157–8. 17 indexed citations
19.
Agudo, Antonio, et al.. (1992). Consumption of alcohol, coffee, and tobacco, and gastric cancer in Spain. Cancer Causes & Control. 3(2). 137–143. 52 indexed citations
20.
Ordï, Jaume, et al.. (1981). [Ectopic ACTH secretion syndrome in a sigmoid neoplasia: an infrequent association].. PubMed. 163(4). 285–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junichi Kaganoi Breakdown of academic impact, for papers by Masahito Tanimizu Breakdown of academic impact, for papers by Manabu Yamamura Breakdown of academic impact, for papers by Chew Wun Wu Breakdown of academic impact, for papers by Stella A. V. Nieuwenburg Breakdown of academic impact, for papers by Roberto Mencarelli Breakdown of academic impact, for papers by Theresa Nguyen Wenker Breakdown of academic impact, for papers by Prachi Patil Breakdown of academic impact, for papers by Reiko Masunaga Breakdown of academic impact, for papers by Balraj Mittal
Rankless by CCL
2026